Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke — Stella

Home/Ischemic Stroke/Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke

View on ClinicalTrials.gov

Recruiting

Back to Ischemic Stroke trials

Ticagrelor Based De-Escalation of Dual Antiplatelet Therapy in Ischemic Stroke

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Iran

Mazandaran province, Sari,Iran, Sari, Mazandaran

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Mazandaran University of Medical Sciences

Enrollment target

~100 participants

Started

April 2024

Primary completion

July 2026

Age range

40 Years and older

Last updated April 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.